The AGE Reader App!
Age Reader APP
The new AGE Reader App allows you to generate a comprehensive Cardiovascular Risk Report based on the AGE Reader measurement. For each patient all visits can be documented and consulted in the easy to use App.

Read more »
Vraag informatie aan
Informatie aanvraag

Wil je meer weten over onze producten? Vraag dan nu informatie aan.


The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or Diagnoptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.

Over het bedrijf

Informatie over Diagnoptics

Informatie voor pati├źnten

Informatie over Diagnoptics producten en Advanced Glycation Endproducts (versuikerde eiwitten)

Informatie voor professionals

Informatie over Advanced Glycation Endproducts, de AGE meting en de klinische validatie.